Soaring Eagle Acquisition - Warrants (23/02/2026) (SRNGW) has a profit margin of -1803.13%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for SRNGW is -1803.13% as of September 2026. That compares with -182.43% in the prior-year period — down 888.4% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Soaring Eagle Acquisition - Warrants (23/02/2026)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, SRNGW's profit margin moved from -182.43% to -1803.13% — a 888.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Soaring Eagle Acquisition - Warrants (23/02/2026)'s valuation or profitability profile.
Against Healthcare companies, SRNGW currently prints -1803.13% for profit margin, while the sector average sits near 19.13%. That is roughly 9525.0% below the sector mean. Large gaps often invite a closer look at Soaring Eagle Acquisition - Warrants (23/02/2026)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Soaring Eagle Acquisition - Warrants (23/02/2026) converts resources into returns. At -1803.13%, SRNGW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -182.43% in the prior-year period — down 888.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SRNGW's profit margin (-1803.13%), review year-over-year change from -182.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.